Comparison of hepatotoxicity of tegoprazan, a novel potassium-competitive acid blocker, with proton pump inhibitors using real-world data: A nationwide cohort study

BACKGROUND: Proton pump inhibitors (PPIs) are acid suppressants that are frequently prescribed in many countries to reduce heartburn. A potassium-competitive acid blocker (P-CAB; tegoprazan) was launched relatively recently that also inhibits gastric acid secretion. This study aimed to compare the h...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Min-Gul, Im, Yong-Jin, Lee, Jong-Hwan, Kim, Eun-Young, Yeom, Sang Woo, Kim, Jong Seung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876560/
https://www.ncbi.nlm.nih.gov/pubmed/36714137
http://dx.doi.org/10.3389/fmed.2022.1076356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876560/
https://www.ncbi.nlm.nih.gov/pubmed/36714137
http://dx.doi.org/10.3389/fmed.2022.1076356

Ejemplares similares